ASX:ILAPharmaceuticals, Biotechnology & Life SciencesPharmaceuticals
Island Pharmaceuticals Ltd
$0.470
+$0.005 (+1.08%)
Day Range
$0.460 – $0.488
52 Week Range
$0.175 – $0.630
Volume
284.86K
Avg Volume (10D)
214.81K
Market Cap
$139.08M
Price Chart
Market Statistics
Open$0.465
Previous Close$0.465
Day High$0.488
Day Low$0.460
52 Week High$0.630
52 Week Low$0.175
Valuation
Market Cap139.08M
Shares Outstanding295.92M
Price to Book16.92
Trading Activity
Volume284.86K
Value Traded136.70K
Bid$0.460 × 6,550
Ask$0.490 × 16,460
Performance
1 Day0.00%
5 Day15.38%
13 Week27.66%
52 Week119.51%
YTD4.65%
Technical Indicators
RSI (14)65.45
50-Day SMA$0.402
200-Day SMA$0.413
Latest News
Biotechnology
Island Pharmaceuticals Expands USAMRIID Agreement for Galidesivir Marburg Study
Island Pharmaceuticals expands USAMRIID CRADA to dose-optimise Galidesivir Marburg study; trials start next quarter; topline results H2 2026, a major milestone.
Biotechnology
Island Pharmaceuticals Strengthens Biodefence Engagement for Galidesivir Advancement
Island Pharmaceuticals strengthens US biodefence push with new adviser Mark Herzog, MC2 roles, and Galidesivir progress toward FDA Animal Rule trials.
Biotechnology
Island Pharma Expands Antiviral Pipeline with Burnet Institute Collaboration and NHMRC Funding
Island Pharma expands antiviral pipeline with Burnet Institute; NHMRC grant of over $780k to back ISLA-101, accelerating Galidesivir MVD program.
Biotechnology
Island Pharma Partners with USAMRIID and Geneva Foundation for Galidesivir under FDA Animal Rule
Island Pharma signs a 3-year CRADA with USAMRIID and Geneva Foundation to fast-track Galidesivir for Marburg under FDA Animal Rule, eyeing NDA.